338 related articles for article (PubMed ID: 10685793)
1. Rheumatoid synovial fluid contains bioactive leukemia inhibitory factor with cartilage degrading activity--another target for chondroprotective intervention.
Bell MC; Carroll GJ
J Rheumatol; 2000 Feb; 27(2):332-8. PubMed ID: 10685793
[TBL] [Abstract][Full Text] [Related]
2. Leukemia inhibitory factor (LIF) binding protein attenuates the phlogistic and abolishes the chondral effects of LIF in goat joints.
Bell M; Carroll GJ; Chapman H; Layton M; Mills J
J Rheumatol; 1997 Dec; 24(12):2394-402. PubMed ID: 9415649
[TBL] [Abstract][Full Text] [Related]
3. Modulation of cartilage proteoglycan metabolism by LIF binding protein.
Hui W; Bell MC; Carroll GJ; Layton MJ
Cytokine; 1998 Mar; 10(3):220-6. PubMed ID: 9576068
[TBL] [Abstract][Full Text] [Related]
4. Leukemia inhibitory factor/differentiation-stimulating factor (LIF/D-factor): regulation of its production and possible roles in bone metabolism.
Ishimi Y; Abe E; Jin CH; Miyaura C; Hong MH; Oshida M; Kurosawa H; Yamaguchi Y; Tomida M; Hozumi M
J Cell Physiol; 1992 Jul; 152(1):71-8. PubMed ID: 1618924
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-1 receptor antagonist inhibits proteoglycan breakdown in antigen induced but not polycation induced arthritis in the rabbit.
Arner EC; Harris RR; DiMeo TM; Collins RC; Galbraith W
J Rheumatol; 1995 Jul; 22(7):1338-46. PubMed ID: 7562769
[TBL] [Abstract][Full Text] [Related]
6. Synovial fluid levels of tumor necrosis factor alpha and oncostatin M correlate with levels of markers of the degradation of crosslinked collagen and cartilage aggrecan in rheumatoid arthritis but not in osteoarthritis.
Manicourt DH; Poilvache P; Van Egeren A; Devogelaer JP; Lenz ME; Thonar EJ
Arthritis Rheum; 2000 Feb; 43(2):281-8. PubMed ID: 10693867
[TBL] [Abstract][Full Text] [Related]
7. Leukaemia inhibitory factor (LIF) suppresses proteoglycan synthesis in porcine and caprine cartilage explants.
Bell MC; Carroll GJ
Cytokine; 1995 Feb; 7(2):137-41. PubMed ID: 7780032
[TBL] [Abstract][Full Text] [Related]
8. [Practical significance of cytokine determination in joint fluid in patients with arthroses or rheumatoid arthritis].
Neidel J; Schulze M; Sova L; Lindschau J
Z Orthop Ihre Grenzgeb; 1996; 134(4):381-5. PubMed ID: 8928570
[TBL] [Abstract][Full Text] [Related]
9. Oncostatin M (OSM) stimulates resorption and inhibits synthesis of proteoglycan in porcine articular cartilage explants.
Hui W; Bell M; Carroll G
Cytokine; 1996 Jun; 8(6):495-500. PubMed ID: 8818547
[TBL] [Abstract][Full Text] [Related]
10. Levels of hepatocyte growth factor in synovial fluid and serum of patients with rheumatoid arthritis and release of hepatocyte growth factor by rheumatoid synovial fluid cells.
Yukioka K; Inaba M; Furumitsu Y; Yukioka M; Nishino T; Goto H; Nishizawa Y; Morii H
J Rheumatol; 1994 Dec; 21(12):2184-9. PubMed ID: 7699616
[TBL] [Abstract][Full Text] [Related]
11. Differential effects of IL-8, LIF (pro-inflammatory) and IL-11 (anti-inflammatory) on TNF-alpha-induced PGE(2)release and on signalling pathways in human OA synovial fibroblasts.
Alaaeddine N; Di Battista JA; Pelletier JP; Kiansa K; Cloutier JM; Martel-Pelletier J
Cytokine; 1999 Dec; 11(12):1020-30. PubMed ID: 10623427
[TBL] [Abstract][Full Text] [Related]
12. Differences in synovial fluid cytokine levels between juvenile and adult rheumatoid arthritis.
De Benedetti F; Pignatti P; Gerloni V; Massa M; Sartirana P; Caporali R; Montecucco CM; Corti A; Fantini F; Martini A
J Rheumatol; 1997 Jul; 24(7):1403-9. PubMed ID: 9228145
[TBL] [Abstract][Full Text] [Related]
13. Oncostatin M induces leukocyte infiltration and cartilage proteoglycan degradation in vivo in goat joints.
Bell MC; Carroll GJ; Chapman HM; Mills JN; Hui W
Arthritis Rheum; 1999 Dec; 42(12):2543-51. PubMed ID: 10615999
[TBL] [Abstract][Full Text] [Related]
14. Suppression of experimental osteoarthritis by adenovirus-mediated double gene transfer.
Wang HJ; Yu CL; Kishi H; Motoki K; Mao ZB; Muraguchi A
Chin Med J (Engl); 2006 Aug; 119(16):1365-73. PubMed ID: 16934183
[TBL] [Abstract][Full Text] [Related]
15. The role of cytokines in osteoarthritis pathophysiology.
Fernandes JC; Martel-Pelletier J; Pelletier JP
Biorheology; 2002; 39(1-2):237-46. PubMed ID: 12082286
[TBL] [Abstract][Full Text] [Related]
16. Turnover of type II collagen and aggrecan in cartilage matrix at the onset of inflammatory arthritis in humans: relationship to mediators of systemic and local inflammation.
Fraser A; Fearon U; Billinghurst RC; Ionescu M; Reece R; Barwick T; Emery P; Poole AR; Veale DJ
Arthritis Rheum; 2003 Nov; 48(11):3085-95. PubMed ID: 14613270
[TBL] [Abstract][Full Text] [Related]
17. Cyclooxygenase 2-dependent prostaglandin E2 modulates cartilage proteoglycan degradation in human osteoarthritis explants.
Hardy MM; Seibert K; Manning PT; Currie MG; Woerner BM; Edwards D; Koki A; Tripp CS
Arthritis Rheum; 2002 Jul; 46(7):1789-803. PubMed ID: 12124863
[TBL] [Abstract][Full Text] [Related]
18. Enhancing effect of IL-17 on IL-1-induced IL-6 and leukemia inhibitory factor production by rheumatoid arthritis synoviocytes and its regulation by Th2 cytokines.
Chabaud M; Fossiez F; Taupin JL; Miossec P
J Immunol; 1998 Jul; 161(1):409-14. PubMed ID: 9647250
[TBL] [Abstract][Full Text] [Related]
19. Concentrations and origins of soluble interleukin 6 receptor-alpha in serum and synovial fluid.
Desgeorges A; Gabay C; Silacci P; Novick D; Roux-Lombard P; Grau G; Dayer JM; Vischer T; Guerne PA
J Rheumatol; 1997 Aug; 24(8):1510-6. PubMed ID: 9263143
[TBL] [Abstract][Full Text] [Related]
20. Interferon-gamma-inducing activity of interleukin-18 in the joint with rheumatoid arthritis.
Yamamura M; Kawashima M; Taniai M; Yamauchi H; Tanimoto T; Kurimoto M; Morita Y; Ohmoto Y; Makino H
Arthritis Rheum; 2001 Feb; 44(2):275-85. PubMed ID: 11229457
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
